Effects of pentoxifylline and its metabolites on platelet aggregation in whole blood from healthy humans

European Journal of Pharmacology

Volumn 581, Issue 3, 2008, Pages 290-295

  Magnusson, Marie ^a   Gunnarsson, Margoth ^a   Berntorp, Erik ^a   Björkman, Sven ^a   Höglund, Peter ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Metabolite effect; Pentoxifylline; Platelet aggregation in whole blood

Indexed keywords

3,7 DIMETHYL 1(3 CARBOXYPROPYL)XANTHINE; 3,7 DIMETYL 1(4 CARBOXYBUTYL)XANTHINE; 3,7 DIMETYL 1(5'HYDROXYHEXYL)XANTHINE; PENTOXIFYLLINE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; PENTOXIFYLLINE; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STEREOISOMERISM;

EID: 38949213020     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.054     Document Type: Article

References (18)

1. Ambrus J.L., Stadler S., and Kulaylat M. Hemorrheologic effects of metabolites of pentoxifylline (Trental). J. Med. 26 (1995) 65-75
2. Angelkort B. Thrombozytenfunktion, plasmatische Blutgerinnung und Fibrinolyse bei chronisch arterieller Verschluss Krankheit. Med. Welt 30 (1979) 1239-1248
3. Beermann B., Ings R., Månsby J., Chamberlain J., and McDonald A. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin. Pharmacol. Ther. 37 (1985) 25-28
4. Bryce T.A., and Burrows J.L. Determination of oxpentifylline and A metabolite, 1-(5¢ -Hydroxyhexyl)-3,7-Dimethylxanthine, by gas-liquid chromatography using a nitrogen-selective detector. J. Chromatogr. 181 (1980) 355-361
5. De la Cruz J.P., Romero M.M., Sanchez P., and Sanchez de la Cuesta F. Antiplatelet effect of pentoxifylline in human whole blood. Gen. Pharmacol. 24 (1993) 605-609
6. Dyskiewicz-Korpanty A.M., Frenkel E.P., and Sarode R. Approach to the assessment of platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin. Appl. Thromb./Hemost. 11 (2005) 25-35
7. Hinze H.J., Bedessem G., and Söder A. Struktur der Ausscheidungsprodukte des 3,7-Dimetyl-1-(5-oxo-hexyl)-xantins (BL 191) beim Menschen. Arzneimittelforschung 22 (1972) 1144-1151
8. Ings R.M.J., Nüdemberg F., Burrows J.L., and Bryce T.A. The pharmacokinetics of oxpentifylline in man when administered by constant intravenous infusion. Eur. J. Clin. Pharmacol. 23 (1982) 539-543
9. Lillibridge J.A., Kalhorn T.F., and Slattery J.T. Metabolism of lisofylline and pentoxifylline in human liver and cytosol. Drug Metab. Dispos. 24 (1996) 1174-1179
10. Magnusson M., Bergstrand I.C., Björkman S., Heijl A., Roth B., and Höglund P. A placebo-controlled study of retinal blood flow changes by pentoxifylline and metabolites in humans. Br. J. Clin. Pharmacol. 61 (2005) 138-147
11. Moher D., Pham B., Ausejo M., Saenz A., Hood S., and Barber G.G. Pharmacological management of intermittent claudication: a meta-analysis of randomised trials. Drugs 59 (2000) 1057-1070
12. Nicklasson M., Björkman S., Roth B., Jönsson M., and Höglund P. Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans. Chirality 14 (2002) 643-652
13. Podczasy J.J., Lee J., and Vucenik I. Evaluation of whole-blood lumiaggregation. Clin. Appl. Thromb./Hemost. 3 (1996) 190-195
14. Radmilović A., Borić Z., Naumović T., Stemenković M., and Mušikivić P. Shunt thrombosis prevention in hemodialysis patients - a double-blind, randomized study: pentoxifylline vs placebo. Angiology 38 (1987) 499-505
15. Samlaska C.P., and Winfield A. Pentoxifylline. J. Am. Acad. Dermatol. 30 (1994) 603-621
16. Smith R.V., Waller E.S., Doluisio J.T., Bauza M.T., Puri S.K., Ho I., and Lassman H.B. Pharmacokinetics of orally administered pentoxifylline in humans. J. Pharm. Sci. 75 (1986) 47-52
17. Vucenik I., and Podczasy J.J. Whole blood lumiaggregation: evaluation of reagents. Clin. Appl. Thromb./Hemost. 4 (1998) 253-256
18. Ward A., and Clissold S.P. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34 (1987) 50-97